
Signify Health SGFY
Annual report 2022
added 02-27-2023
Signify Health Total Assets 2011-2026 | SGFY
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Signify Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.74 B | 2.13 B | 1.52 B | 1.39 B | 602 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.13 B | 602 M | 1.48 B |
Quarterly Total Assets Signify Health
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.72 B | - | 2.27 B | 2.13 B | 2.13 B | 2.09 B | 2.17 B | 1.52 B | 1.52 B | 1.52 B | 1.52 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.27 B | 1.52 B | 1.86 B |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
324 M | $ 5.51 | -2.13 % | $ 88.4 M | ||
|
HealthStream
HSTM
|
511 M | $ 21.25 | 0.09 % | $ 646 M | ||
|
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | ||
|
OptimizeRx Corporation
OPRX
|
183 M | $ 6.96 | -3.06 % | $ 119 M | ||
|
Phreesia
PHR
|
370 M | $ 11.65 | 3.28 % | $ 636 M | ||
|
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | ||
|
Evolent Health
EVH
|
1.82 B | $ 2.38 | 4.85 % | $ 223 M | ||
|
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | ||
|
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | ||
|
Schrödinger
SDGR
|
726 M | $ 11.57 | 1.49 % | $ 850 M | ||
|
Zhongchao
ZCMD
|
25.9 M | $ 1.78 | -1.11 % | $ 9.27 M | ||
|
MTBC
MTBC
|
87.6 M | - | -0.58 % | $ 51.7 M | ||
|
Teladoc Health
TDOC
|
2.86 B | $ 5.52 | -0.9 % | $ 973 M | ||
|
GoodRx Holdings
GDRX
|
1.39 B | $ 2.04 | -0.97 % | $ 787 M | ||
|
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | ||
|
10x Genomics
TXG
|
965 M | $ 20.43 | -2.3 % | $ 2.39 B | ||
|
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | ||
|
Omnicell
OMCL
|
2.12 B | $ 35.2 | 0.74 % | $ 1.62 B | ||
|
Health Catalyst
HCAT
|
503 M | $ 1.1 | - | $ 76.9 M | ||
|
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | ||
|
HealthEquity
HQY
|
3.38 B | $ 83.85 | 1.67 % | $ 7.22 B | ||
|
SCWorx Corp.
WORX
|
6.35 M | $ 0.13 | 2.95 % | $ 190 K | ||
|
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
607 M | $ 17.79 | 0.23 % | $ 1.53 B | ||
|
So-Young International
SY
|
2.74 B | $ 2.83 | -11.29 % | $ 225 M | ||
|
Veeva Systems
VEEV
|
8.98 B | $ 178.28 | 0.1 % | $ 29.2 B |